These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9024633)

  • 61. The status of p53 in cancer cells affects the role of autophagy in tumor radiosensitisation.
    Zheng R; Yao Q; Du S; Ren C; Sun Q; Xu Z; Lin X; Yuan Y
    J BUON; 2014; 19(2):336-41. PubMed ID: 24965389
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents.
    Huang TS; Kuo ML; Shew JY; Chou YW; Yang WK
    Oncogene; 1996 Aug; 13(3):625-32. PubMed ID: 8760304
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Advances in the study of p53 in response to DNA damage].
    Wang YJ; Sun H; Liu GT; Chen XG
    Yao Xue Xue Bao; 2011 Dec; 46(12):1413-9. PubMed ID: 22375412
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A potential role of p53 and WOX1 in mitochondrial apoptosis (review).
    Chang NS
    Int J Mol Med; 2002 Jan; 9(1):19-24. PubMed ID: 11744990
    [TBL] [Abstract][Full Text] [Related]  

  • 65. p53-dependent cell death signaling in neurons.
    Morrison RS; Kinoshita Y; Johnson MD; Guo W; Garden GA
    Neurochem Res; 2003 Jan; 28(1):15-27. PubMed ID: 12587660
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
    Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
    Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.
    Mirzayans R; Andrais B; Kumar P; Murray D
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452953
    [TBL] [Abstract][Full Text] [Related]  

  • 68. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The subcellular distribution of the p53 tumour suppressor, and organismal ageing.
    Wesierska-Gadek J; Schmid G
    Cell Mol Biol Lett; 2005; 10(3):439-53. PubMed ID: 16217555
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway.
    Tong X; O'Kelly J; Xie D; Mori A; Lemp N; McKenna R; Miller CW; Koeffler HP
    Oncogene; 2004 Jun; 23(28):4847-55. PubMed ID: 15077166
    [TBL] [Abstract][Full Text] [Related]  

  • 71. p53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2.
    Aliouat-Denis CM; Dendouga N; Van den Wyngaert I; Goehlmann H; Steller U; van de Weyer I; Van Slycken N; Andries L; Kass S; Luyten W; Janicot M; Vialard JE
    Mol Cancer Res; 2005 Nov; 3(11):627-34. PubMed ID: 16317088
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Apoptosis and the cell cycle.
    Meikrantz W; Schlegel R
    J Cell Biochem; 1995 Jun; 58(2):160-74. PubMed ID: 7673324
    [TBL] [Abstract][Full Text] [Related]  

  • 73. p53: upstream, downstream and off stream. Review of the 8th p53 workshop (Dundee, July 5-9, 1996).
    Oren M; Prives C
    Biochim Biophys Acta; 1996 Dec; 1288(3):R13-9. PubMed ID: 9011182
    [No Abstract]   [Full Text] [Related]  

  • 74. BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest.
    Ongusaha PP; Ouchi T; Kim KT; Nytko E; Kwak JC; Duda RB; Deng CX; Lee SW
    Oncogene; 2003 Jun; 22(24):3749-58. PubMed ID: 12802282
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes.
    Qin JZ; Chaturvedi V; Denning MF; Bacon P; Panella J; Choubey D; Nickoloff BJ
    Oncogene; 2002 May; 21(19):2991-3002. PubMed ID: 12082529
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
    Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
    Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gene expression profile in a glioma cell line resistant to cell death induced by the chimeric tumor suppressor-1 (CTS-1), a dominant-positive variant of p53--the role of NFkappaB.
    Seznec J; Weit S; Naumann U
    Carcinogenesis; 2010 Mar; 31(3):411-8. PubMed ID: 20015865
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
    Hansen RS; Braithwaite AW
    Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
    [TBL] [Abstract][Full Text] [Related]  

  • 79. p53 modulation of anchorage independent growth and experimental metastasis.
    Nikiforov MA; Hagen K; Ossovskaya VS; Connor TM; Lowe SW; Deichman GI; Gudkov AV
    Oncogene; 1996 Oct; 13(8):1709-19. PubMed ID: 8895517
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chemical induced alterations in p53 signaling.
    Högberg J; Silins I; Stenius U
    EXS; 2009; 99():181-208. PubMed ID: 19157062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.